Abstract
Introduction: Acute myocardial infarction is known with high mortality. The benefits of fibrinolytic administration in STEMI are time dependent. The purpose of this study is to evaluate the door-to-needle time for fibrinolytic therapy in STEMI patients.Methods: A cross sectional study of all patients who had STEMI was carried out to evaluate the management of STEMI. The duration from door-to-ECG time, door-to-needle time and the factors that contribute to the time frame in receiving treatment was reviewed. The outcomes and complications from fibrinolytic therapy were documented as well. The outcomes of the delayed in administering the treatment were also analyzed in the study.Result: Out of 19 patients received fibrinolytics within 30 minutes, 16 patients (84.2%) had good outcome. In 17 patients received fibrinolytics between 30 minutes to 1 hour, 6 patients (35.2%) had good outcome. In 15 patients received fibrinolytics more than 1 hour, 8 patients (53.3%) had good outcome.Conclusion: This study showed that a shorter door-to-needle time results in better outcome.Bangladesh Journal of Medical Science Vol.16(3) 2017 p.407-412
Highlights
Acute myocardial infarction is known with high mortality
The purpose of this study is to evaluate the doorto-needle time for fibrinolytic therapy in ST elevation myocardial infarction (STEMI) patients presented to Hospital Sultan Haji Ahmad Shah, Temerloh, to evaluate whether recommended
A cross sectional study of all patients who had STEMI in ETD, HoSHAS from 1st January 2014 till 30th April 2014 was carried out to evaluate the management of STEMI
Summary
Acute myocardial infarction is known with high mortality. The benefits of fibrinolytic administration in STEMI are time dependent. The purpose of this study is to evaluate the door-to-needle time for fibrinolytic therapy in STEMI patients. Result: Out of 19 patients received fibrinolytics within 30 minutes, 16 patients (84.2%) had good outcome. In 17 patients received fibrinolytics between 30 minutes to 1 hour, 6 patients (35.2%) had good outcome. In 15 patients received fibrinolytics more than 1 hour, 8 patients (53.3%) had good outcome. Conclusion: This study showed that a shorter door-to-needle time results in better outcome. Mortality from acute myocardial infarction is influenced by the speed of which reperfusion therapy is delivered to the patient. The purpose of this study is to evaluate the doorto-needle time for fibrinolytic therapy in STEMI patients presented to Hospital Sultan Haji Ahmad Shah, Temerloh, to evaluate whether recommended
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
